Astrana Health (ASTH) Competitors $33.70 -1.39 (-3.96%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ASTH vs. HQY, BILI, MARA, QXO, ETSY, LYFT, NVEI, TNET, CARG, and DXCShould you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include HealthEquity (HQY), Bilibili (BILI), MARA (MARA), QXO (QXO), Etsy (ETSY), Lyft (LYFT), Nuvei (NVEI), TriNet Group (TNET), CarGurus (CARG), and DXC Technology (DXC). These companies are all part of the "business services" industry. Astrana Health vs. HealthEquity Bilibili MARA QXO Etsy Lyft Nuvei TriNet Group CarGurus DXC Technology HealthEquity (NASDAQ:HQY) and Astrana Health (NASDAQ:ASTH) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation, community ranking and dividends. Which has stronger earnings and valuation, HQY or ASTH? Astrana Health has higher revenue and earnings than HealthEquity. Astrana Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.15B7.15$55.71M$1.0987.11Astrana Health$1.72B1.10$60.72M$1.3025.92 Is HQY or ASTH more profitable? HealthEquity has a net margin of 8.41% compared to Astrana Health's net margin of 3.63%. HealthEquity's return on equity of 9.70% beat Astrana Health's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity8.41% 9.70% 6.08% Astrana Health 3.63%9.37%5.32% Which has more volatility and risk, HQY or ASTH? HealthEquity has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Do analysts rate HQY or ASTH? HealthEquity currently has a consensus price target of $110.71, suggesting a potential upside of 16.60%. Astrana Health has a consensus price target of $65.17, suggesting a potential upside of 93.37%. Given Astrana Health's higher probable upside, analysts clearly believe Astrana Health is more favorable than HealthEquity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 1 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.93Astrana Health 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.89 Does the media favor HQY or ASTH? In the previous week, Astrana Health had 4 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for Astrana Health and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.07 beat Astrana Health's score of 0.60 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Does the MarketBeat Community favor HQY or ASTH? HealthEquity received 522 more outperform votes than Astrana Health when rated by MarketBeat users. However, 78.57% of users gave Astrana Health an outperform vote while only 70.04% of users gave HealthEquity an outperform vote. CompanyUnderperformOutperformHealthEquityOutperform Votes53370.04% Underperform Votes22829.96% Astrana HealthOutperform Votes1178.57% Underperform Votes321.43% Do insiders and institutionals hold more shares of HQY or ASTH? 99.6% of HealthEquity shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 2.2% of HealthEquity shares are held by company insiders. Comparatively, 8.5% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryHealthEquity beats Astrana Health on 10 of the 19 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Astrana Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASTH vs. The Competition Export to ExcelMetricAstrana HealthManagement consulting services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.90B$2.29B$5.13B$9.07BDividend YieldN/A2.40%5.08%4.23%P/E Ratio25.929.5489.7417.18Price / Sales1.1033.691,116.12116.95Price / Cash28.2238.3142.8237.86Price / Book3.195.024.774.78Net Income$60.72M$115.15M$120.15M$225.60M7 Day Performance-10.44%66.51%-1.92%-1.23%1 Month Performance-19.97%49.91%11.47%3.36%1 Year PerformanceN/A83.01%30.52%16.60% Astrana Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASTHAstrana Health4.1784 of 5 stars$33.70-4.0%$65.17+93.4%N/A$1.90B$1.72B25.921,800High Trading VolumeHQYHealthEquity3.2935 of 5 stars$93.37-2.4%$110.71+18.6%+47.1%$8.09B$1.15B87.723,150BILIBilibili2.1676 of 5 stars$19.24-2.9%$19.69+2.3%+78.1%$7.97B$3.19B-20.958,801Gap DownMARAMARA3.6692 of 5 stars$24.77+9.0%$24.56-0.9%-9.7%$7.97B$387.51M31.159Analyst ForecastInsider TradeAnalyst RevisionGap UpQXOQXO1.6408 of 5 stars$16.92+4.8%N/AN/A$6.93B$54.52M-1.77195News CoveragePositive NewsETSYEtsy4.4563 of 5 stars$61.40+4.1%$63.17+2.9%-32.0%$6.91B$2.75B31.262,420LYFTLyft4.6851 of 5 stars$14.28+1.0%$17.77+24.5%-9.9%$5.92B$5.46B-88.382,945NVEINuvei1.5819 of 5 stars$33.99+0.0%$32.08-5.6%+33.1%$4.82B$1.19B226.602,202Positive NewsHigh Trading VolumeTNETTriNet Group4.4715 of 5 stars$93.36-2.2%$117.00+25.3%-25.0%$4.63B$4.97B18.313,600Positive NewsCARGCarGurus3.6005 of 5 stars$38.42+2.0%$37.86-1.4%+50.9%$3.98B$914.24M-81.891,343Insider TradePositive NewsDXCDXC Technology2.4309 of 5 stars$21.46flat$20.89-2.7%-6.3%$3.88B$13.67B268.28130,000Options Volume Related Companies and Tools Related Companies HealthEquity Competitors Bilibili Competitors MARA Competitors QXO Competitors Etsy Competitors Lyft Competitors Nuvei Competitors TriNet Group Competitors CarGurus Competitors DXC Technology Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ASTH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.